211 related articles for article (PubMed ID: 16647299)
1. Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells.
Yam P; Jensen M; Akkina R; Anderson J; Villacres MC; Wu J; Zaia JA; Yee JK
Mol Ther; 2006 Aug; 14(2):236-44. PubMed ID: 16647299
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
3. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
Dupuy FP; Mouly E; Mesel-Lemoine M; Morel C; Abriol J; Cherai M; Baillou C; Nègre D; Cosset FL; Klatzmann D; Lemoine FM
J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
6. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo transduction and expansion of CD4+ lymphocytes from HIV + donors: prelude to a ribozyme gene therapy trial.
Leavitt MC; Yu M; Wong-Staal F; Looney DJ
Gene Ther; 1996 Jul; 3(7):599-606. PubMed ID: 8818647
[TBL] [Abstract][Full Text] [Related]
9. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J; Akkina R
Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
11. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of CXCR4 expression by SDF-KDEL in CD34(+) hematopoietic stem cells: An anti-human immunodeficiency virus strategy.
Zhang JC; Sun L; Nie QH; Huang CX; Jia ZS; Wang JP; Lian JQ; Li XH; Wang PZ; Zhang Y; Zhuang Y; Sun YT; Bai X
J Virol Methods; 2009 Oct; 161(1):30-7. PubMed ID: 19463855
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
Tewari D; Notkins AL; Zhou P
J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
[TBL] [Abstract][Full Text] [Related]
14. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector.
Bai Y; Soda Y; Izawa K; Tanabe T; Kang X; Tojo A; Hoshino H; Miyoshi H; Asano S; Tani K
Gene Ther; 2003 Aug; 10(17):1446-57. PubMed ID: 12900759
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of RANTES-KDEL on inhibition of HIV-1 in CD34(+) human hematopoietic stem cells (hHSC).
Sun L; Zhang Y; Huang CX; Qu XL; Zhang Y; Zhang JC; Wei X; Zhuang Y; Zhai S; Peng MJ; Jiang H; Hao CQ; Li YH; Lu J; Lian JQ; Sun YT; Bai XF
J Virol Methods; 2008 Dec; 154(1-2):194-9. PubMed ID: 18706447
[TBL] [Abstract][Full Text] [Related]
16. A genetic strategy to control expression of human blood group antigens in red blood cells generated in vitro.
Bagnis C; Chapel S; Chiaroni J; Bailly P
Transfusion; 2009 May; 49(5):967-76. PubMed ID: 19175544
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.
BouHamdan M; Duan LX; Pomerantz RJ; Strayer DS
Gene Ther; 1999 Apr; 6(4):660-6. PubMed ID: 10476226
[TBL] [Abstract][Full Text] [Related]
18. Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells.
Kurre P; Anandakumar P; Kiem HP
Gene Ther; 2006 Feb; 13(4):369-73. PubMed ID: 16208421
[TBL] [Abstract][Full Text] [Related]
19. Stem cells as vehicles for gene therapy: novel strategy for HIV infection.
Ho AD; Li X; Lane TA; Yu M; Law P; Wong-Staal F
Stem Cells; 1995 Dec; 13 Suppl 3():100-5. PubMed ID: 8747996
[TBL] [Abstract][Full Text] [Related]
20. Pre-clinical evaluation of an in vitro selection protocol for the enrichment of transduced CD34+ cell-derived human dendritic cells.
Evans JT; Cravens P; Gatlin J; Kelly PF; Lipsky PE; Garcia JV
Gene Ther; 2001 Sep; 8(18):1427-35. PubMed ID: 11571583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
